{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:43:26Z","timestamp":1785833006012,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000133","name":"AHRQ","doi-asserted-by":"publisher","award":["R18HS027389"],"award-info":[{"award-number":["R18HS027389"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ypmed.2022.107345","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T23:32:20Z","timestamp":1668036740000},"page":"107345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Total cost of care associated with opioid use disorder treatment"],"prefix":"10.1016","volume":"166","author":[{"given":"Mohammad Usama","family":"Toseef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Durfee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Jean","family":"Podewils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"McEwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Hanratty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Everhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2022.107345_bb0005","series-title":"3MTM Clinical Risk Groups: Measuring Risk, Managing Care","author":"3M Health Information Systems","year":"2022"},{"key":"10.1016\/j.ypmed.2022.107345_bb0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/B:APIH.0000003017.78877.56","article-title":"Mental and substance use disorders among Medicaid recipients: prevalence estimates from two national surveys","volume":"31","author":"Adelmann","year":"2003","journal-title":"Adm. Policy Ment. Health Ment. Health Serv. Res."},{"key":"10.1016\/j.ypmed.2022.107345_bb0015","first-page":"1","article-title":"The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review","volume":"16","author":"Alexander","year":"2021","journal-title":"Substance Abuse Treatment Prev. Pol."},{"key":"10.1016\/j.ypmed.2022.107345_bb0020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ADM.0000000000000310","article-title":"Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact","volume":"11","author":"Brooklyn","year":"2017","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.ypmed.2022.107345_bb0025","series-title":"Mandatory Medicaid State Plan Coverage of Medication-Assisted Treatment","author":"Centers for Medicare and Medicaid Services","year":"2020"},{"key":"10.1016\/j.ypmed.2022.107345_bb0030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ajem.2021.08.058","article-title":"Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations","volume":"50","author":"Chandran","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ypmed.2022.107345_bb0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Rev. Psychiatry"},{"key":"10.1016\/j.ypmed.2022.107345_bb0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev-publhealth-040617-013517","article-title":"Modeling health care expenditures and use","volume":"39","author":"Deb","year":"2018","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.ypmed.2022.107345_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev.publhealth.20.1.125","article-title":"Methods for analyzing health care utilization and costs","volume":"20","author":"Diehr","year":"1999","journal-title":"Annu. Rev. Public Health"},{"issue":"7","key":"10.1016\/j.ypmed.2022.107345_bb0050","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamapsychiatry.2021.0247","article-title":"Cost-effectiveness of treatments for opioid use disorder","volume":"78","author":"Fairley","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ypmed.2022.107345_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108350","article-title":"The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017","volume":"218","author":"Florence","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.ypmed.2022.107345_bb0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/cid\/ciq243","article-title":"The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection","volume":"52","author":"Gardner","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ypmed.2022.107345_bb0065","author":"Health Resources & Services Administration (HRSA)"},{"key":"10.1016\/j.ypmed.2022.107345_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108617","article-title":"Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder","volume":"221","author":"Jacka","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2022.107345_bb0075","doi-asserted-by":"crossref","DOI":"10.13063\/2327-9214.1181","article-title":"Augmenting predictive modeling tools with clinical insights for care coordination program design and implementation","volume":"3","author":"Johnson","year":"2015","journal-title":"eGEMs"},{"key":"10.1016\/j.ypmed.2022.107345_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ypmed.2022.107345_bb0085","article-title":"The economic burden of the opioid epidemic on states: the case of Medicaid","volume":"25","author":"Leslie","year":"2019","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ypmed.2022.107345_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108158","article-title":"A clash of epidemics: impact of the COVID-19 pandemic response on opioid overdose","volume":"120","author":"Linas","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.ypmed.2022.107345_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/15360280903544877","article-title":"Costs of opioid abuse and misuse determined from a Medicaid database","volume":"24","author":"McAdam-Marx","year":"2010","journal-title":"J Pain Palliative Care Pharmacother."},{"key":"10.1016\/j.ypmed.2022.107345_bb0100","series-title":"Overdose Death Rates","author":"National Institute on Drug Abuse","year":"2022"},{"key":"10.1016\/j.ypmed.2022.107345_bb0105","series-title":"The Opioid Epidemic and Medicaid's Role in Facilitating Access to Treatment","author":"Orgera","year":"2019"},{"key":"10.1016\/j.ypmed.2022.107345_bb0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2019.07.002","article-title":"Monitoring opioid addiction and treatment: do you know if your population is engaged?","volume":"202","author":"Prieto","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2022.107345_bb0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1377\/hlthaff.2009.1087","article-title":"Medication adherence leads to lower health care use and costs despite increased drug spending","volume":"30","author":"Roebuck","year":"2011","journal-title":"Health Aff."},{"key":"10.1016\/j.ypmed.2022.107345_bb0120","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health","author":"SAMHSA","year":"2021"},{"key":"10.1016\/j.ypmed.2022.107345_bb0125","series-title":"Stata Statistical Software: Release 16","author":"StataCorp","year":"2019"},{"key":"10.1016\/j.ypmed.2022.107345_bb0130","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"key":"10.1016\/j.ypmed.2022.107345_bb0135","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1176\/appi.ps.55.8.886","article-title":"Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia","volume":"55","author":"Weiden","year":"2004","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.ypmed.2022.107345_bb0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.ypmed.2022.107345_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","article-title":"Development of a cascade of care for responding to the opioid epidemic","volume":"45","author":"Williams","year":"2019","journal-title":"Am. J. Drug Alcohol Abuse"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522003954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522003954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:17:40Z","timestamp":1758795460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743522003954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":29,"alternative-id":["S0091743522003954"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107345","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total cost of care associated with opioid use disorder treatment","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107345"}}